[文献资料]参 考 文 献

Final results of a multi-center，double-blind，randomized，placebo-controlled phase Ⅱ study to assess the efficacy of MAGE-A3 immunotherapeutic as adjuvant therapy in stage IB / Ⅱ non-small cell lung cancer.Updated survival analysis in patients with stage Ⅲ ......